Business Description
Phathom Pharmaceuticals is a New Jersey-based company founded in 2018 that brings new medicines to patients suffering from digestive and stomach conditions across the United States. Its main product, VOQUEZNA, along with companion treatment packages, has successfully completed late-stage clinical testing for conditions such as acid reflux, recurring heartburn, and bacterial stomach infections. The company is working to expand the reach of these treatments to additional patient groups, including teenagers dealing with related esophageal conditions.
